Atlas Trials

Early-Line Anti-EGFR Therapy to Facilitate Retreatment for Select Patients With mCRC

Clinical trial NCT04587128 · ACTIVE_NOT_RECRUITING

Trial details

NCT number
NCT04587128
Sponsor
University of Wisconsin, Madison
Status
ACTIVE_NOT_RECRUITING
Phase
Phase 2
Study type
INTERVENTIONAL
Metastatic Colorectal Cancer
Start date
2020-10-19
Primary completion
2029-10-01
Enrollment
34

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.